Iovance Biotherapeutics, Inc.
IOVA
$6.98
$0.467.06%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.17% | -12.86% | -8.28% | -24.32% | -26.99% |
| Total Receivables | 70.37% | 15.25% | 18.90% | 19.71% | 89.65% |
| Inventory | 11.55% | -10.94% | 0.31% | 34.04% | 78.91% |
| Prepaid Expenses | -23.14% | -18.68% | -6.42% | 45.57% | 13.39% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 9.88% | -9.00% | -3.14% | -13.94% | -12.39% |
|
|
|||||
| Total Current Assets | 9.88% | -9.00% | -3.14% | -13.94% | -12.39% |
| Net Property, Plant & Equipment | 1.46% | 8.18% | 7.75% | -2.15% | -4.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -10.92% | -5.70% | -1.09% | -6.99% | 0.32% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -23.53% | 128.60% | 110.26% | 129.63% | 143.33% |
| Total Assets | 0.89% | -4.25% | 0.30% | -8.69% | -5.90% |
|
|
|||||
| Total Accounts Payable | -18.10% | 31.45% | -19.45% | -1.42% | 56.76% |
| Total Accrued Expenses | -4.40% | 7.76% | 39.26% | 13.94% | 29.87% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -66.88% | -58.95% | -60.89% | -36.97% | -29.43% |
| Total Finance Division Other Current Liabilities | -69.66% | -36.69% | -4.46% | 112.26% | 553.11% |
| Total Other Current Liabilities | -69.66% | -36.69% | -4.46% | 112.26% | 553.11% |
| Total Current Liabilities | -17.27% | 5.48% | 13.09% | 6.55% | 37.93% |
|
|
|||||
| Total Current Liabilities | -17.27% | 5.48% | 13.09% | 6.55% | 37.93% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.92% | -0.78% | 0.08% | -31.90% | -34.88% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -15.53% | -4.22% | -1.51% | -1.71% | 8.78% |
| Total Liabilities | -14.10% | 2.53% | 7.28% | -6.89% | 6.73% |
|
|
|||||
| Common Stock & APIC | 10.18% | 9.24% | 11.68% | 10.66% | 10.02% |
| Retained Earnings | -11.08% | -14.15% | -16.40% | -17.24% | -17.54% |
| Treasury Stock & Other | -37.30% | 100.99% | 1,671.70% | -0.86% | 3,865.59% |
| Total Common Equity | 5.38% | -6.01% | -1.66% | -9.20% | -9.11% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | -33.33% | -33.33% | -33.33% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | -33.33% | -33.33% | -33.33% |
|
|
|||||
| Total Common Equity | 5.38% | -6.01% | -1.66% | -9.20% | -9.11% |
| Total Preferred Equity | 0.00% | 0.00% | -33.33% | -33.33% | -33.33% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.38% | -6.01% | -1.66% | -9.20% | -9.11% |
|
|
|||||